Safety, tolerability, and immunogenicity of a SARS-CoV-2 recombinant spike RBD protein vaccine: A randomised, double-blind, placebo-controlled, phase 1-2 clinical trial (ABDALA Study)
SARS-CoV-2 重组刺突蛋白 RBD 疫苗的安全性、耐受性和免疫原性:一项随机、双盲、安慰剂对照的 1-2 期临床试验(ABDALA 研究)
期刊:EClinicalMedicine
影响因子:10
doi:10.1016/j.eclinm.2022.101383
Hernández-Bernal, Francisco; Ricardo-Cobas, Maria C; Martín-Bauta, Yenima; Navarro-Rodríguez, Zadis; Piñera-Martínez, Marjoris; Quintana-Guerra, Joel; Urrutia-Pérez, Karen; Urrutia-Pérez, Klaudia; Chávez-Chong, Cristina O; Azor-Hernández, Jorge L; Rodríguez-Reinoso, José L; Lobaina-Lambert, Leonardo; Colina-Ávila, Elizabeth; Bizet-Almeida, Jacqueline; Rodríguez-Nuviola, Jeniffer; Del Valle-Piñera, Sergio; Ramírez-Domínguez, Mayara; Tablada-Ferreiro, Elisangela; Alonso-Valdés, Marel; Lemos-Pérez, Gilda; Guillén-Nieto, Gerardo E; Palenzuela-Díaz, Ariel; Noa-Romero, Enrique; Limonta-Fernández, Miladys; Fernández-Ávila, Juan M; Ali-Mros, Nabil A; Del Toro-Lahera, Lianne; Remedios-Reyes, Rossana; Ayala-Ávila, Marta; Muzio-González, Verena L